US Patent Issued to GENETIC DIAGNOSTICS AND THERAPY 21, Obschestvo s ogranchennoi otvetsvennostju REKOMBITEKH on March 11 for "DNA vector for targeted gene therapy" (British Inventor)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,246,073, issued on March 11, was assigned to GENETIC DIAGNOSTICS AND THERAPY 21 LTD (London) and Obschestvo s ogranchennoi otvetsvennostju REKOMBITEKH (Moscow).

"DNA vector for targeted gene therapy" was invented by Anton Gamolski (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to biotechnology, to gene therapy DNA vectors, a Escherichia coli strain JM110-NAS, a method of its production and selection of gene therapy DNA vector for targeted gene therapy. The method of a gene therapy DNA vector for targeted gene therapy includes construction of a 2408 bp vector containing a 688 bp replication origin, a 467 bp transcription te...